Form SEC STAFF ACTION Shangzhaitong Holding
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zymeworks ZW191 shows 64.5% response rate in ovarian cancer trial
- Vertex's povetacicept hits key endpoints in Phase 3 kidney disease trial
- TG Therapeutics reports Phase 1 azer-cel data in progressive MS
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share